Question 1

What do medical sources say about Amphetamine (Adderall, Dexedrine, Dexedrine Spansules, Dextrostat, Liquadd, ProCentra, Zenzedi) during pregnancy?

Accepted Answer

1st Trimester: MotherToBaby reports that studies of prescribed mixed amphetamine salts and dextroamphetamine have not found a higher chance of birth defects, and a large first-trimester cohort of 5,571 amphetamine exposures found no increase in overall or heart malformations. MotherToBaby says miscarriage findings are mixed; the current U.S. Adderall XR label says available research has not identified a drug-associated risk of major birth defects or miscarriage, while also stating that it may cause fetal harm and noting premature delivery and low birth weight. A 2025 Norwegian study linked ADHD medicines as a group to miscarriage; its reported drug-specific increases were for methylphenidate, lisdexamfetamine, and atomoxetine, not amphetamine. FDA's boxed warning says Adderall XR has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction; misuse and abuse can result in overdose and death. Ask your provider about your situation. 2nd Trimester: MotherToBaby reports mixed findings on poor growth, low birth weight, early delivery, high blood pressure, and preeclampsia with prescribed amphetamines, and says ADHD or other factors may also affect those outcomes. In a large U.S. Medicaid cohort, first-half amphetamine/dextroamphetamine use was associated with higher preeclampsia risk after adjustment, while most other placental outcomes did not show clear increases. The U.S. label says amphetamines may lower blood flow to the placenta and notes early delivery and low birth weight; available studies do not give a separate estimate for the second trimester alone. Recent Norway-Sweden and Australian cohorts found some higher preterm, blood-pressure, or diabetes outcomes with ADHD medicines overall, but these results were not specific to amphetamine and may reflect ADHD or other factors. FDA's boxed warning says Adderall XR has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction; misuse and abuse can result in overdose and death. Ask your provider about your situation. 3rd Trimester: MotherToBaby reports mixed findings on early delivery and high blood pressure or preeclampsia in studies of prescribed amphetamines, and says the condition being treated may also affect these outcomes. A large U.S. study found that continuing stimulant treatment after 20 weeks was associated with preterm birth compared with stopping, but that comparison combined amphetamine/dextroamphetamine and methylphenidate. A Norway-Sweden study found duration-related preterm-birth signals for ADHD medicines during weeks 22 to 36, and a U.S. cohort found similar directions in amphetamine- and methylphenidate-stratified analyses; neither provides a separate third-trimester estimate or settles amphetamine-specific risk. The current U.S. label notes increased risks of premature delivery and low birth weight and tells clinicians to monitor exposed newborns for feeding problems, irritability, agitation, or excessive drowsiness. FDA's boxed warning says Adderall XR has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction; misuse and abuse can result in overdose and death. Ask your provider about your situation.

Question 2

What do medical sources say about Amphetamine (Adderall, Dexedrine, Dexedrine Spansules, Dextrostat, Liquadd, ProCentra, Zenzedi) while breastfeeding?

Accepted Answer

MotherToBaby reports that there are no studies of the mixed amphetamine-dextroamphetamine combination during breastfeeding, while small studies of dextroamphetamine or amphetamine found no problems in infant health, growth, or development. The 2024 pilot followed 13 children exposed to amphetamine stimulants during breastfeeding; its abstract reported normal neurodevelopment and no significant adverse effects. LactMed's account of that study lists nonspecific symptoms in five children, though overall development was reported normal, and long-term effects remain unknown. LactMed says some experts allow therapeutic doses with infant monitoring, while the current Adderall XR label says breastfeeding is not recommended during treatment. FDA's boxed warning says Adderall XR has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction; misuse and abuse can result in overdose and death. Ask your provider about your situation.

Question 3

Where do sources disagree on Amphetamine (Adderall, Dexedrine, Dexedrine Spansules, Dextrostat, Liquadd, ProCentra, Zenzedi) in pregnancy or breastfeeding?

Accepted Answer

Pregnancy product-label advice and clinical treatment planning The UK Amfexa product information says dexamfetamine use during pregnancy is not recommended and says women planning pregnancy should discontinue it. U.S. Adderall XR labeling says published epidemiologic and postmarketing data have not identified a drug-associated risk of major birth defects or miscarriage. Scoten et al. recommend individualized planning and considering pharmacotherapy for moderate or severe ADHD after weighing treatment and untreated-condition risks. The UK product information takes a more restrictive position, while the U.S. label reports no identified risk for major birth defects or miscarriage but also describes possible premature delivery and low birth weight. The clinical review weighs medication exposure against the effects of inadequately treated ADHD. These are different label and clinical-review approaches to observational evidence, not proof that either approach applies to every patient. Keep the rating at guidance. The evidence does not support a universal avoid recommendation, but the preeclampsia finding, possible later pregnancy outcomes, and differing product-label advice warrant an individualized discussion.

Amphetamine

Amphetamine — Breastfeeding

What the research shows

What's in it / what was tested

Sources disagree

Options sources describe

Beyond pregnancy

All sources

Similar medications